Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells.

[1]  H. G. van der Poel,et al.  PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy , 2014, International journal of molecular sciences.

[2]  Paul Polakis,et al.  Site-specific antibody drug conjugates for cancer therapy , 2013, mAbs.

[3]  Asher Mullard,et al.  Maturing antibody–drug conjugate pipeline hits 30 , 2013, Nature Reviews Drug Discovery.

[4]  P. Moore,et al.  Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity , 2012, Clinical Cancer Research.

[5]  H. Hamada,et al.  Epigenetic Modulation Enhances the Therapeutic Effect of Anti–IL-13Rα2 Antibody in Human Mesothelioma Xenografts , 2011, Clinical Cancer Research.

[6]  A. van Waarde,et al.  Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo , 2010, Molecular Cancer.

[7]  T. Yamashita,et al.  Selective gene transfer into neurons via Na,K‐ATPase β1. Targeting gene transfer with monoclonal antibody and adenovirus vector , 2008, The journal of gene medicine.

[8]  Takeshi Shimamura,et al.  The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy. , 2006, Neurosurgical focus.

[9]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[10]  M. Uhlén,et al.  Differential IgG-binding characteristics of staphylococcal protein A, streptococcal protein G, and a chimeric protein AG. , 1989, Journal of immunology.

[11]  B Guss,et al.  Structure of the IgG‐binding regions of streptococcal protein G. , 1986, The EMBO journal.

[12]  G. Buck,et al.  Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage beta. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[13]  高橋 秀.  Neural cell adhesion molecule 2 as a target molecule for prostate and breast cancer gene therapy , 2011 .

[14]  鈴木 一弘.  Exploration of target molecules for prostate cancer gene therapy , 2007 .

[15]  D. Lappi,et al.  Mab-ZAP: a tool for evaluating antibody efficacy for use in an immunotoxin. , 2000, BioTechniques.